NSE - Delayed Quote
INR
Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)
1,899.00
-17.00
(-0.89%)
At close: September 4 at 3:15:04 PM GMT+5:30
Loading chart for SUNPHARMA.NS
- Previous Close
1,916.00 - Open
1,912.00 - Bid 1,899.00 x --
- Ask --
- Day's Range
1,895.00 - 1,917.30 - 52 Week Range
1,548.00 - 2,046.90 - Volume
761,333 - Avg. Volume
2,052,819 - Market Cap (intraday)
4.556T - Beta (5Y Monthly) 0.12
- PE Ratio (TTM)
37.69 - EPS (TTM)
50.39 - Earnings Date Nov 5, 2026
- Forward Dividend & Yield 16.00 (0.84%)
- Ex-Dividend Date Jul 7, 2026
- 1y Target Est
2,167.21
Recent News
View MorePerformance Overview
Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
SUNPHARMA.NS
11.43%
S&P BSE SENSEX (^BSESN)
10.21%
1-Year Return
SUNPHARMA.NS
21.11%
S&P BSE SENSEX (^BSESN)
5.21%
3-Year Return
SUNPHARMA.NS
75.98%
S&P BSE SENSEX (^BSESN)
16.59%
5-Year Return
SUNPHARMA.NS
152.74%
S&P BSE SENSEX (^BSESN)
31.63%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (5yr expected)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
20.19%
-
Return on Assets (ttm)
--
-
Return on Equity (ttm)
--
-
Revenue (ttm)
599.11B
-
Net Income Avi to Common (ttm)
120.96B
-
Diluted EPS (ttm)
50.39
Balance Sheet and Cash Flow
-
Total Cash (mrq)
335.17B
-
Total Debt/Equity (mrq)
5.52%
-
Levered Free Cash Flow (ttm)
--
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
